Neogen Launches Enhanced Genomic Test For Cats
Portfolio Pulse from Benzinga Newsdesk
Neogen Corporation has launched My CatScan 2.0, an upgraded version of its genetic screening test for cats. The new version includes 39 new diseases and genetic traits, offering information on over 120 genetic health conditions. The test uses a noninvasive cheek swab method and provides insights tailored to specific needs.
June 13, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neogen Corporation has launched an upgraded version of its genetic screening test for cats, My CatScan 2.0, which now offers information on over 120 genetic health conditions.
The launch of My CatScan 2.0 expands Neogen's product offerings in the genetic screening market for cats. This upgraded version includes 39 new diseases and genetic traits, which could attract more customers and potentially increase revenues for the company. As a result, the stock price is likely to go up in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100